NCT04246268 - Assessment of the INVOcell Intravaginal Culture System | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

March 31, 2022

Conditions

Infertility

Interventions

DEVICE

INVOcell

Female participants undergoing in vitro fertilization (IVF) and/or Intracytoplasmic Sperm Injection (ICSI) for assisted reproduction will be asked to participate.

Trial Locations (4)

23452

The New Hope Center for Reproductive Medicine, Virginia Beach

29169

Piedmont Reproductive Endocrinology Group, West Columbia

29615

Piedmont Reproductive Endocrinology Group, Greenville

78229

Fertility Center of San Antonio, San Antonio